Skip Navigation

Colorado board won’t put a price cap on a massively expensive cystic fibrosis drug

coloradosun.com Colorado board won’t cap price of cystic fibrosis drug that costs average of $234,439 per patient per year

The Colorado Prescription Drug Advisory Board declined to set a price cap on the massively expensive cystic fibrosis drug Trikafta

Colorado board won’t cap price of cystic fibrosis drug that costs average of $234,439 per patient per year
7
7 comments
7 comments